MENU

BOLT Bolt Biotherapeutics Inc Forecast, Technical & Fundamental Analysis

Bolt Biotherapeutics Inc is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer... Show more

BOLT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
BOLT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

BOLT is expected to report earnings to fall 25.75% to -320 cents per share on November 05

Bolt Biotherapeutics Inc BOLT Stock Earnings Reports
Q3'26
Est.
$-3.20
Q1'26
Missed
by $3.95
Q4'25
Missed
by $3.54
Q3'25
Missed
by $3.42
Q2'25
Missed
by $4.15
The last earnings report on May 12 showed earnings per share of -430 cents, missing the estimate of -36 cents. With 53.84K shares outstanding, the current market capitalization sits at 7.06M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
900 Chesapeake Drive
Phone
+1 650 665-9295
Employees
23
Web
https://www.boltbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HSDT2.100.24
+12.90%
Solana Company
EDHL4.070.10
+2.52%
Everbright Digital Holding Limited
TS52.66-0.02
-0.04%
Tenaris S A
FDUS19.70-0.11
-0.56%
Fidus Investment Corp
LBTYB12.70-0.30
-2.31%
Liberty Global Ltd

BOLT and Stocks

Correlation & Price change

A.I.dvisor tells us that BOLT and XENE have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BOLT and XENE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BOLT
1D Price
Change %
BOLT100%
+16.40%
XENE - BOLT
31%
Poorly correlated
+1.74%
NRXP - BOLT
30%
Poorly correlated
+1.42%
ARRY - BOLT
30%
Poorly correlated
-0.42%
KRRO - BOLT
29%
Poorly correlated
+1.70%
SPRO - BOLT
28%
Poorly correlated
+0.83%
More
Bolt Biotherapeutics (BOLT) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com